Effect of avastin combined with loratadine in the treatment of patients with chronic idiopathic urticaria
-
摘要: 目的 观察慢性自发性荨麻疹患者应用阿伐斯汀联合氯雷他定片的治疗效果。 方法 选取本院收治的慢性自发性荨麻疹患者80例,分为治疗组和对照组,每组40例,比较2组治疗后的各项指标。 结果 治疗后,治疗组的治疗总有效率为95.00%, 高于对照组的77.50%, 差异有统计学意义(P<0.05); 治疗组的血清IgE、C3、C4水平,以及疾病复发率低于对照组,差异有统计学意义(P<0.05); 与对照组相比,治疗组的最大风团显著缩小,持续发作时间缩短、瘙痒评分降低,差异有统计学意义(P<0.05)。 结论 慢性自发性荨麻疹患者应用阿伐斯汀联合氯雷他定片,可以改善机体的炎性因子水平,缓解临床症状,降低疾病的复发率。Abstract: Objective To observe the effect of avastin combined with loratadine tablets in the treatment of patients with chronic idiopathic urticaria. Methods Totally 80 patients with chronic idiopathic urticaria in our hospital were selected and divided into treatment group and control group, with 40 cases in each group. The indicators after treatment were compared between the two groups. Results After treatment, the total effective rate was 95.00% in the treatment group, which was significantly higher than 77.50% in the control group(P<0.05). The serum levels of IgE, C3 and C4 and recurrence rate of disease in the treatment group were significantly lower than those in the control group(P<0.05). Compared with the control group, the maximum wind mass in the treatment group reduced significantly, the duration of persistent attack shortened significantly, and the pruritus score significantly decreased(P<0.05). Conclusion Avastin combined with loratadine tablets is effective in treatment of patients with chronic idiopathic urticarial, which can significantly improve the levels of inflammatory factors, relieve clinical symptoms, and reduce the recurrence rate of the disease.
-
Keywords:
- chronic idiopathic urticaria /
- loratadine tablets /
- avastin /
- inflammatory factors
-
-
胡立红. 玉屏风颗粒联合枸地氯雷他定片治疗慢性荨麻疹临床疗效[J]. 陕西中医, 2017, 38(6): 759-761. 石岩硕, 王祁民, 邱学佳, 等. 雷公藤多苷片联合地氯雷他定治疗慢性荨麻疹疗效和安全性的Meta分析[J]. 中国中药杂志, 2019, 44(16): 3551-3557. 唐海燕, 娄方璐, 刘毅, 等. 阿伐斯汀联合玉屏风颗粒治疗慢性荨麻疹临床研究[J]. 中国麻风皮肤病杂志, 2017, 33(8): 487-489. 衡鲲. 左西替利嗪联合地氯雷他定治疗慢性荨麻疹80例临床观察[J]. 中国皮肤性病学杂志, 2017, 31(5): 588-590. 沈悦, 张懿, 徐晶, 等. 枸地氯雷他定联合甘草酸二胺治疗慢性荨麻疹66例临床观察[J]. 中国皮肤性病学杂志, 2017, 31(8): 117-120. 李妍, 徐薇, 顾恒, 等. 阿伐斯汀联合氯雷他定治疗慢性难治性荨麻疹的多中心随机对照研究[J]. 中华皮肤科杂志, 2020, 53(5): 319-323. 赵丽娜, 钱伊瑞, 蒋杰, 等. 枸地氯雷他定对比氯雷他定治疗慢性荨麻疹有效性与安全性的Meta分析[J]. 中国皮肤性病学杂志, 2018, 32(2): 135-139. 陈圳伟. 阿伐斯汀与左西替利嗪治疗变态反应性皮肤病的疗效观察[J]. 黑龙江中医药, 2019, 48(1): 6-7. 许仕军, 徐尚兰, 陈明清. 枸地氯雷他定片联合自体全血穴位注射治疗慢性荨麻疹的疗效观察[J]. 四川医学, 2017, 38(3): 88-89. 张丹露, 季梅, 傅英华, 等. 当归饮子加减方联合阿伐斯汀治疗慢性荨麻疹疗效观察[J]. 中国中西医结合皮肤性病学杂志, 2016, 15(3): 155-157. 伍婕. 复方甘草酸苷联合枸地氯雷他定治疗慢性特发性荨麻疹的临床研究[J]. 现代药物与临床, 2017, 32(4): 693-697. 林志秋, 杨利蓉, 高中香. 自血疗法联合氯雷他定治疗慢性荨麻疹的疗效观察[J]. 中国全科医学, 2017, 20(12): 104-105. 于淼. 枸地氯雷他定与阿伐斯汀递减疗法治疗慢性荨麻疹的临床观察[J]. 锦州医科大学学报, 2019, 40(4): 75-76 +90.
徐延峰, 杜威萍, 骆志成, 等. 枸地氯雷他定治疗慢性荨麻疹的疗效及对血清白细胞介素23和33、趋化因子PARC/CCL-18的影响[J]. 中华皮肤科杂志, 2019, 52(5): 337-339. 王福东, 曹慧. 枸地氯雷他定与依巴斯汀递减疗法治疗慢性荨麻疹的效果对比[J]. 中国中西医结合皮肤性病学杂志, 2018, 17(3): 35-38. 郑蔚波. 枸地氯雷他定与阿伐斯汀递减疗法治疗慢性荨麻疹的临床效果对比分析[J]. 中国处方药, 2018, 16(9): 65. 夏华. 枸地氯雷他定联合玉屏风颗粒序贯治疗慢性荨麻疹的临床观察[J]. 中国中西医结合皮肤性病学杂志, 2018, 17(5): 55-57. 张文献. 枸地氯雷他定与阿伐斯汀递减疗法治疗慢性荨麻疹的临床效果对比分析[J]. 中国医药指南, 2019, 17(36): 22-23.
计量
- 文章访问数: 463
- HTML全文浏览量: 125
- PDF下载量: 16
下载:
苏公网安备 32100302010246号